MayTech Global Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-387,083
Closed -$21.5M 28
2025
Q3
$21.5M Sell
387,083
-23,158
-6% -$1.36M 2.24% 18
2025
Q2
$26.7M Buy
410,241
+22,710
+6% +$1.54M 2.76% 17
2025
Q1
$26.9M Buy
387,531
+9,779
+3% +$808K 3.49% 14
2024
Q4
$32.5M Buy
377,752
+123,200
+48% +$13.3M 3.83% 12
2024
Q3
$30.3M Buy
254,552
+31,475
+14% +$4.2M 4% 12
2024
Q2
$31.8M Buy
223,077
+3,835
+2% +$508K 4.77% 7
2024
Q1
$28.2M Buy
219,242
+2,587
+1% +$308K 4.61% 10
2023
Q4
$22.4M Buy
216,655
+506
+0.2% +$50K 4.53% 9
2023
Q3
$19.7M Sell
216,149
-29,459
-12% -$2.6M 4.58% 9
2023
Q2
$19.9M Buy
245,608
+34,294
+16% +$2.8M 3.94% 11
2023
Q1
$16.8M Sell
211,314
-5,120
-2% -$363K 4.62% 10
2022
Q4
$14.6M Buy
216,434
+86,966
+67% +$5.1M 4.86% 9
2022
Q3
$6.45M Buy
+129,468
New +$6.94M 2.35% 19

Other funds holding NVO

MayTech Global Investments's NVO Position: Q4 2025 in Review

MayTech Global Investments sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 387,083 shares — an estimated $21.5M sold.

MayTech Global Investments first reported a position in NVO in Q3 2022 and held it in 13 quarters. The position peaked at $32.5M in Q4 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • MayTech Global Investments reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • MayTech Global Investments sold 387,083 Novo Nordisk shares in Q4 2025, an estimated $21.5M.
  • MayTech Global Investments first reported a position in Novo Nordisk in Q3 2022 and held it in 13 quarters.
  • MayTech Global Investments's Novo Nordisk position peaked at $32.5M in Q4 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on MayTech Global Investments's 13F filing for Q4 2025, filed 13 Feb 2026.